Biphasic effect of danazol on human vascular endothelial cell permeability and f-actin cytoskeleton dynamics

Biochemical and Biophysical Research Communications

Volumn 421, Issue 4, 2012, Pages 707-712

  Thomas, Gregory W ^a   Rael, Leonard T ^a   Bar Or, Raphael ^a   Mains, Charles W ^b   Slone, Denetta S ^a   Boyd, Shelley R ^c   Bar Or, David ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b ST ANTHONY HOSPITAL   (United States)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Danazol; Endothelial cell; F Actin; Trans endothelial electrical resistance; Vascular permeability

Indexed keywords

ACTIN; ANDROGEN RECEPTOR; DANAZOL; ESTROGEN RECEPTOR; F ACTIN; FORSKOLIN;

ARTICLE; BINDING COMPETITION; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; STRESS FIBER;

ACTINS; CELLS, CULTURED; CYTOSKELETON; DANAZOL; ESTROGEN ANTAGONISTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PERMEABILITY;

EID: 84861220835     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.066     Document Type: Article

References (23)

1. Rubanyi G.M., Kauser K., Johns A. Role of estrogen receptors in the vascular system. Vascular Pharmacology 2002, 38:81-88.
2. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. JAMA 1991, 265:1861-1867.
3. Yang X.P., Reckelhoff J.F. Estrogen, hormonal replacement therapy and cardiovascular disease. Current Opinion in Nephrology and Hypertension 2011, 20:133-138.
4. Michels G., Hoppe U.C. Rapid actions of androgens. Frontiers in Neuroendocrinology 2008, 29:182-198.
5. Liu J., Wu S., Wei H., Zhou K., Ruan Y., Lai W. Effects of sex hormones and their balance on the proliferation of rat vascular endothelial cells. Hormone Research 2002, 58:16-20.
6. Chen X., Zhang M., Jiang C., Guo W., Liu H., Wei S. Estrogen attenuates VEGF-initiated blood-retina barrier breakdown in male rats. Hormone and Metabolic Research 2011, 43:614-618.
7. Williamson J.R., Rowold E., Chang K., Marvel J., Tomlinson M., Sherman W.R., Ackermann K.E., Berger R.A., Kilo C. Sex steroid dependency of diabetes-induced changes in polyol metabolism, vascular permeability, and collagen cross-linking. Diabetes 1986, 35:20-27.
8. Morales D.E., McGowan K.A., Grant D.S., Maheshwari S., Bhartiya D., Cid M.C., Kleinman H.K., Schnaper H.W. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763.
9. Prossnitz E.R., Arterburn J.B., Sklar L.A. GPR30: a G protein-coupled receptor for estrogen. Molecular and Cellular Endocrinology 2007, 265-266:138-142.
10. Thomas G.W., Rael L.T., Shimonkevitz R., Curtis C.G., Bar-Or R., Bar-Or D. Effects of danazol on endothelial cell function and angiogenesis. Fertility and Sterility 2007, 88:1065-1070.
11. Vandenbroucke E., Mehta D., Minshall R., Malik A.B. Regulation of endothelial junctional permeability. Annals of the New York Academy of Sciences 2008, 1123:134-145.
12. Kumar P., Shen Q., Pivetti C.D., Lee E.S., Wu M.H., Yuan S.Y. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Reviews in Molecular Medicine 2009, 11:e19.
13. Beato M., Klug J. Steroid hormone receptors: an update. Human Reproduction Update 2000, 6:225-236.
14. Foradori C.D., Weiser M.J., Handa R.J. Non-genomic actions of androgens. Frontiers in Neuroendocrinology 2008, 29:169-181.
15. Bogatcheva N.V., Verin A.D. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvascular Research 2008, 76:202-207.
16. Navarro P., Caveda L., Breviario F., Mandoteanu I., Lampugnani M.G., Dejana E. Catenin-dependent and -independent functions of vascular endothelial cadherin. The Journal of Biological Chemistry 1995, 270:30965-30972.
17. Garcia J.G., Liu F., Verin A.D., Birukova A., Dechert M.A., Gerthoffer W.T., Bamberg J.R., English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. Journal of Clinical Investigation 2001, 108:689-701.
18. Komatsu S., Ikebe M. The phosphorylation of myosin II at the Ser1 and Ser2 is critical for normal platelet-derived growth factor induced reorganization of myosin filaments. Molecular Biology of the Cell 2007, 18:5081-5090.
19. Cheng J., Watkins S.C., Walker W.H. Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. Endocrinology 2007, 148:2066-2074.
20. Jenkin G., Cookson C.I., Thorburn G.D. The interaction of human endometrial and myometrial steroid receptors with danazol. Clinical Endocrinology 1983, 19:377-388.
21. Ye L., Martin T.A., Parr C., Harrison G.M., Mansel R.E., Jiang W.G. Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. Journal of Cellular Physiology 2003, 196:362-369.
22. Dmowski W.P., A synthetic steroid with diverse biologic effects Danazol. The Journal of Reproductive Medicine 1990, 35:69-74. discussion 74-65.
23. Huscher D., Thiele K., Gromnica-Ihle E., Hein G., Demary W., Dreher R., Zink A., Buttgereit F. Dose-related patterns of glucocorticoid-induced side effects. Annals of the Rheumatic Diseases 2009, 68:1119-1124.